Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains seven ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

We investigated the immunotherapeutic potential of Poly6 combined with HBsAg vaccination against hepatitis B virus infection in C57BL/6 mice or an HBV transgenic mouse model. Results ... embryos were ...

In a new study, researchers at Case Western Reserve University School of Medicine have determined that a protein called NF-kB ...

Gilead Sciences shares NHS England’s commitment to eliminate the virus through a broad public health strategy that will enable all individuals living with hepatitis C to be cured of this life ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver ...

Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly ... and Stopping ART in Model of SIV Infection Leads to Control ...

Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017).